Pages that link to "Q45290174"

The following pages link to Impairment of retinal increment thresholds in Huntington's disease (Q45290174):

Displaying 20 items.

• Color naming deficits and attention-deficit/hyperactivity disorder: a retinal dopaminergic hypothesis (Q25255003) (← links)
• Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington's disease (Q33640990) (← links)
• Effects of estrogen on higher-order cognitive functions in unstressed human females may depend on individual variation in dopamine baseline levels (Q34417751) (← links)
• Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease (Q34624963) (← links)
• Ophthalmology issues in schizophrenia (Q35912687) (← links)
• The ubiquitin-proteasome system in retinal health and disease. (Q38075859) (← links)
• Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models. (Q38235229) (← links)
• Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users (Q44445337) (← links)
• Fine-structural analysis and connexin expression in the retina of a transgenic model of Huntington's disease (Q45081901) (← links)
• Optical coherence tomography findings in Huntington's disease: a potential biomarker of disease progression (Q45289374) (← links)
• Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease (Q45293191) (← links)
• Is gardening a stimulating activity for people with advanced Huntington's disease? (Q45296497) (← links)
• Enhanced retinal responses in Huntington's disease patients. (Q46490717) (← links)
• Colour vision in migraine: selective deficits for S-cone discriminations (Q46504511) (← links)
• Retinal single-layer analysis with optical coherence tomography shows inner retinal layer thinning in Huntington's disease as a potential biomarker (Q50050949) (← links)
• Parallel increase of heterochromatic increment threshold and postadaptation thresholds in Parkinson's disease and in neuroleptic treatment (Q50526033) (← links)
• Impaired colour discrimination in Huntington's disease (Q50767763) (← links)
• Retinal dysfunction in a presymptomatic patient with Huntington's disease. (Q53402662) (← links)
• The influence of established and new antiepileptic drugs on visual perception. 1. A placebo-controlled, double-blind, single-dose study in healthy volunteers (Q73992554) (← links)
• Attentional blink and putative noninvasive dopamine markers: Two experiments to consolidate possible associations (Q92515148) (← links)